There is no most effective drug for the treatment of cerebral infarction. Cerebral infarction refers to ischemic necrosis or softening of limited brain tissues caused by ischemia and hypoxia due to impaired blood supply to the brain. The principle of treatment is to improve blood circulation in the ischemic area of the brain as early as possible and promote the recovery of neurological function. Commonly used thrombolytic drugs such as alteplase; antiplatelet aggregation drugs such as aspirin, clopidogrel; cerebroprotective agents such as edaravone, cytarabine and so on. 1. Thrombolytic drugs: Thrombolysis in the window period, commonly used alteplase. 2. Antiplatelet aggregating agents: can prevent new thrombus formation and avoid aggravation of symptoms, commonly used aspirin, clopidogrel. 3. Brain protection agent: it can reduce ischemic brain damage by lowering brain metabolism, commonly used edaravone, cytarabine, and so on. 4. Improvement of cerebral circulation drugs: commonly used flunarizine, nimodipine, nicardipine, butalbital, betahistine. 5. Fiber-lowering drugs: optional drugs include bacitracin, fibrinolytic enzyme and ankylase. Existence of primary disease should be actively treated, commonly used drugs such as labetalol, nicardipine, nifedipine and other drugs to control blood pressure; through metformin, insulin treatment to control blood sugar; the use of atorvastatin, resuvastatin, etc. to lower blood lipids and so on. Cerebral infarction patients should be under the guidance of doctors, according to the specific conditions, to develop individualized diagnosis and treatment plan. The medication should be strictly in accordance with the doctor’s prescription, do not blindly pursue special-effect drugs.